---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-24-079101"
form_type: "8-K"
ticker: "GRDX"
cik: "0001604191"
company_name: "GridAI Technologies Corp."
filed_at: "2024-07-11T23:59:59+00:00"
generated_at: "2026-05-31T21:47:24.497919+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Entero Therapeutics raises $1.9M via warrant exercise inducement; issues new warrants for 3.5M shares

## Summary
- Gross proceeds of ~$1.9M from cash exercise of 1,762,674 existing warrants at a reduced price of $1.09 per share.
- In exchange, the company issued new inducement warrants to purchase up to 3,525,348 shares at $1.09, exercisable for 5 years from stockholder approval.
- Roth Capital Partners acted as financial advisor, receiving ~$96,000 in fees plus expense reimbursement.
- Company agreed to file a resale registration statement for the new warrant shares by July 25, 2024.
- Transaction structured as an at-market warrant inducement under Nasdaq rules; no variable rate transactions until July 10, 2025.

## SEC filing metadata
- accession: 0001104659-24-079101
- form_type: 8-K
- ticker: GRDX
- cik: 0001604191
- company_name: GridAI Technologies Corp.
- filed_at: 2024-07-11T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 3.02, 3.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1604191/000110465924079101/0001104659-24-079101-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1604191/000110465924079101/tm2419264d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-24-079101
- JSON: https://secwatch.observer/filing/0001104659-24-079101.json
- Plain text: https://secwatch.observer/filing/0001104659-24-079101.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.